CD44 Immunohistochemical Expression in Central and Peripheral Parts of Prostatic Adenocarcinoma: An Institutional Study
<i>Background and Objectives</i>: Prostate cancer is one of the most commonly diagnosed cancers in the male population and the fifth leading cause of cancer death worldwide in men as of 2022. One of the potential biomarkers that can predict the progression of the disease is the transmemb...
Saved in:
| Main Authors: | Romano Oguic, Antun Grskovic, Josip Spanjol, Ivana Mikolasevic, Gordana Djordjevic |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/60/12/2032 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic Implications of Modified Gleason Score and Gleason Grade Group in Histopathologic Study of Prostatic Adenocarcinoma: A Cross-sectional Study
by: Netra Prakash Kori, et al.
Published: (2024-11-01) -
Evaluating the role of CD44 in oral squamous cell carcinoma and potentially malignant disorders – An immunohistochemical study
by: Tharani V, et al.
Published: (2024-06-01) -
Exploring the efficacy of AMACR, ERG, and AR immunostains in prostatic adenocarcinoma and their association with novel grade groups
by: Mohamed O. Andarawi, et al.
Published: (2025-02-01) -
Prostate Specific Antigen Level and Gleason Score in Indonesian Prostate Cancer Patients
by: Muhammad Imam Al Kautsar Herawan, et al.
Published: (2024-09-01) -
Expression of cytokeratin 19 in prostatic adenocarcinoma: a systematic review
by: Sina Shahshenas, et al.
Published: (2025-01-01)